Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lymph-node inspired hydrogels enhance CAR expression and proliferation of CAR T cells

  • Castellote-Borrell, Miquel|||0000-0001-7703-2228
  • Domingo, Marc|||0000-0003-1627-3823
  • Merlina, Francesca|||0000-0001-5040-1687
  • Lu, Huixia|||0000-0003-2731-5283
  • Colell, Salut|||0000-0002-2132-2856
  • Bachiller, Mireia|||0000-0002-6153-4722
  • Juan, Manel|||0000-0002-3064-1648
  • Guedan, Sonia|||0000-0002-9605-0760
  • Faraudo, Jordi|||0000-0002-6315-4993
  • Guasch, Judith|||0000-0002-3571-4711
Chimeric antigen receptor (CAR) T therapy has shown unprecedented results in clinical practice, including long-term complete responses. One of the current challenges of CAR T therapy is to optimize its production in order to lower its cost. Currently, the in vivo activation of T cells by dendritic cells is replicated ex vivo using polymeric magnetic beads coated with antibodies to induce polyclonal T cell activation. However, current practice overlooks the importance of the complex environment that constitutes the lymph nodes, in which T cells activate and proliferate in vivo. Hydrogels are an ideal candidate material for mimicking the properties of natural tissues such as lymph nodes. In this study, key conditions of the composition, stiffness, and microarchitecture of hydrogels were experimentally and theoretically investigated to optimize primary human CAR T cell culture, focusing on CAR expression and proliferation. Poly(ethylene glycol)-heparin hydrogels featuring interconnected pores of 120 μm and an intermediate stiffness of 3.1 kPa were identified as the most suitable conditions for promoting CAR T cell expression and expansion. Specifically, these hydrogels increased the percentage of CAR+ cells by 50% and doubled the replication index compared to suspension cultures. In conclusion, these newly engineered hydrogels are an interesting tool to help improve CAR T cell manufacture and ultimately advance towards a broader clinical implementation of CAR T cell therapy.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lymph-Node Inspired Hydrogels Enhance CAR Expression and Proliferation of CAR T Cells

  • Castellote Borrell, Miquel
  • Domingo, Marc
  • Merlina, Francesca
  • Lu, Huixia
  • Colell, Salut
  • Bachiller, Mireia
  • Juan, Manel
  • Guedan, Sonia
  • Faraudo, Jordi
  • Guasch, Judith
Chimeric antigen receptor (CAR) T therapy has shown unprecedented results in clinical practice, including long-term complete responses. One of the current challenges of CAR T therapy is to optimize its production in order to lower its cost. Currently, the in vivo activation of T cells by dendritic cells is replicated ex vivo using polymeric magnetic beads coated with antibodies to induce polyclonal T cell activation. However, current practice overlooks the importance of the complex environment that constitutes the lymph nodes, in which T cells activate and proliferate in vivo. Hydrogels are an ideal candidate material for mimicking the properties of natural tissues such as lymph nodes. In this study, key conditions of the composition, stiffness, and microarchitecture of hydrogels were experimentally and theoretically investigated to optimize primary human CAR T cell culture, focusing on CAR expression and proliferation. Poly(ethylene glycol)-heparin hydrogels featuring interconnected pores of 120 μm and an intermediate stiffness of 3.1 kPa were identified as the most suitable conditions for promoting CAR T cell expression and expansion. Specifically, these hydrogels increased the percentage of CAR+ cells by 50% and doubled the replication index compared to suspension cultures. In conclusion, these newly engineered hydrogels are an interesting tool to help improve CAR T cell manufacture and ultimately advance toward a broader clinical implementation of CAR T cell therapy., This research was supported by “La Caixa” Foundation through the program “CaixaImpulse” (grant no. CI23-20216) and the Spanish Government through grants CNS2023-144236 (MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR), 2024ICT149, PID2020-115296RA-I00 and PID2021-124297NB-C33 (MICIU/AEI/10.13039/501100011033), the “Severo Ochoa” program for Centers of Excellence awarded to ICMAB (CEX2023-001263 S), the FPI fellowships PRE2021-098161 and PRE2020-093689 awarded to M.C-B. and M.D., respectively, and the “Ramón y Cajal” program (RYC-2018-024442-I) granted to S.G. We also thank the Government of Catalonia (AGAUR) for the grant 2021SGR01519 as well as the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck for Medical Research (Heidelberg, Germany)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., Peer reviewed